As Associate Director of Cell & Gene Therapy Forecasting, you will lead global forecasting activities for Vertex’s rapidly evolving cell and gene therapy portfolio, with an emphasis on the Heme franchise and the emerging Type 1 Diabetes program. You will develop robust forecasts across time horizons, partner cross-functionally to shape commercial strategy, and ensure the integration of the latest market, competitive, and clinical intelligence. You will collaborate closely with commercial, medical, finance, manufacturing, operations, and marketing science partners to deliver high-quality analytical support that informs business decisions, scenario planning, and the long-range portfolio outlook. This role requires demonstrated excellence in in-line forecasting, experience working in complex or rapidly evolving therapeutic areas, and the ability to operate with both strategic vision and operational precision. You will help shape forecasting frameworks for long-term, potentially curative therapies where traditional analogs and market behaviors may not apply—requiring creativity, methodological innovation, and strong collaborative leadership.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
1,001-5,000 employees